Bupropion hydrochloride
- Product NDC
- 50090-0862
- 11-digit product format
- 500900862
- Labeler code
- 50090
- Product ID
- 50090-0862_199f6d0c-bfe2-44cc-b44b-3c3c9c12faa1
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Bupropion hydrochloride
- Dosage form
- TABLET, FILM COATED, EXTENDED RELEASE
- Route
- ORAL
- Labeler
- A-S Medication Solutions
- Application
- ANDA078866
- Marketing category
- ANDA
- Marketing start
- 2020-03-01
- Marketing end
- 0000-00-00
- Substance
- BUPROPION HYDROCHLORIDE
- Active strength
- 150 mg/1
- Pharmacologic classes
- Aminoketone [EPC], Dopamine Uptake Inhibitors [MoA], Increased Dopamine Activity [PE], Increased Norepinephrine Activity [PE], Norepinephrine Uptake Inhibitors [MoA]
- NDC exclude flag
- No
- Listing certified through
- 2023-12-31
- Current FDA listing
- Historical FDA.report record
DailyMed Dashboard NDC Coverage#
NDC, Dashboard title, SPL version table| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|
| 50090-0862 | BUPROPION HYDROCHLORIDE TABLET, FILM COATED, EXTENDED RELEASE [A-S MEDICATION SOLUTIONS] | 9 | Legacy NDC | 20231210_fbfb1966-8450-49b4-b329-7812f0f83462.zip |
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 50090-0862-0 | 50090086200 | 60 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (50090-0862-0) | 2020-03-01 | 0000-00-00 | No | No | Current |
| 50090-0862-1 | 50090086201 | 30 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (50090-0862-1) | 2020-03-01 | 0000-00-00 | No | No | Current |
| 50090-0862-2 | 50090086202 | 180 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (50090-0862-2) | 2020-03-01 | 0000-00-00 | No | No | Current |
| 50090-0862-3 | 50090086203 | 90 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (50090-0862-3) | 2022-08-15 | 0000-00-00 | No | No | Current |